By Steve Holland and Michael Erman WASHINGTON, Aug 31 (Reuters) – U.S. President Donald Trump announced a new round of drug-pricing agreements with international pharmaceutical companies and some
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)